𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

✍ Scribed by J. Feliu; P. Borrega; A. León; L. López-Gómez; M. López; J. Castro; C. Belda-Iniesta; J. Barriuso; V. Martínez; M. González-Barón

Publisher
Springer
Year
2010
Tongue
English
Weight
287 KB
Volume
67
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 1 study of fixed dose rate gemci
A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer
✍ Weijing Sun; Maureen R. Hewitt; Marry R. Theobald; Diane Hershock; Daniel G. Hal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND. The combination of a fixed dose rate (FDR) infusion of gemcitabine and irinotecan may have a synergistic effect in the treatment of patients with advanced and metastatic pancreatic and biliary cancer. The current study was conducted to determine the dose‐limiting toxicit